Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T17:27:03.275Z.
Calculation as of: 2026-10-06T17:27:03.275Z.
Quote observation: 2026-10-06T17:24:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fc2e94c8beea8e322b310e9b25a1b89028fd55b2fc6a2790cf1d230843e32158
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Incannex Healthcare Limited
Market Cap
$37.90M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.61M
EV/EBITDA Ratio
10.54x
TTM Avg
9.64x
3Y Avg
45.33x
5Y Avg
52.62x
Market Cap
$39.53M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $37.90M | N/A | N/A | N/A | N/A |
| QT Imaging Holdings, Inc. (QTI)vs › | $37.45M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.61M | 10.54x | 9.64x | 45.33x | 52.62x |
| Edesa Biotech, Inc. (EDSA)vs › | $37.09M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.69M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.53M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $36.26M | 18.38x | 31.88x | 41.18x | 41.18x |
| DocGo Inc. (DCGO)vs › | $35.76M | N/A | 6.76x | 19.14x | 45.56x |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.42M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.23M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
